Merck Sharp & Dohme B.V. - M&A Summary and Business Overview

Medical ProductsCompany

Merck Sharp & Dohme B.V. M&A Summary

Merck Sharp & Dohme B.V. has acquired 2 companies. It has also divested 3 assets.

It’s largest disclosed sale occurred in 2013, when it sold Saphris to Forest Laboratories Holdings for $240M. Merck Sharp & Dohme B.V. has acquired in 1 US state. The Company’s most targeted sectors include information technology (50%) and life science (50%).

Merck Sharp & Dohme B.V. Business Overview

Where is Merck Sharp & Dohme B.V. headquartered?

Merck Sharp & Dohme B.V. is headquartered in Haarlem, Netherlands.

What sector is Merck Sharp & Dohme B.V. in?

Merck Sharp & Dohme B.V. is a medical products company.

When was Merck Sharp & Dohme B.V. founded?

Merck Sharp & Dohme B.V. was founded in 1954.

M&A Summary

  • M&A Total Activity5
    • M&A Buy Activity2
    • M&A Sell Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 3

Merck Sharp & Dohme B.V.

Waarderweg 39,
Haarlem, 2031
Netherlands,
+31 23 515 3153
www.msd.nl

Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc. (NYSE:MRK). Merck Sharp & Dohme B.V provides medicines for diabetes, High blood pres pressure and rheumatic disease patients.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 2 - - - - - 2
Sell (0.0/yr) # 3 - - - - - 3
vol $240M $240M
  5

Most Recent M&A

Company Date Value Type
Vree Health LLC 2015-10-21 - Divestiture
Annandale, New Jersey · www.vreehealth.com
Saphris 2013-12-02 240M USD Divestiture
, United States
Merck Sharp & Dohme - Pharma­ceutical Skin Care Product(Propyless) 2013-11-08 - Divestiture
, Sweden
Schering Corp. 2012-05-01 - Merger
Kenilworth, New Jersey
Vree Health LLC 2012-01-01 - Add-on Acquisition
Annandale, New Jersey · www.vreehealth.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Information Technology 1 (50%) - 1 (33%) -
Life Science 1 (50%) - - -
Consumer Products - - 1 (33%) -
Medical Products - - 1 (33%) 240M (100%)
Total 2 - 3 $240M

By Geo

State/Country Buy Value Sell Value
United States 2 - 2 240M
  New Jersey 2 - 1 -
Sweden - - 1 -
Domestic - - - -
Cross-border 2 (100%) - 3 (100%) 240M (100%)
Total 2 - 3 $240M

Deal Values

sell # Total
$100M to $1B 1 $240M
TOTAL $240M
Largest Saphris
$240M (2013-12-02)

M&A Connections

Deals
Divested to
Strategic(s)
100%
3 (100%)

 Subscribe to unlock this and 201,882
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Merck Sharp & Dohme B.V.

Medical Products Companies , Netherlands Companies